News

3 Reasons INCY is Risky and 1 Stock to Buy Instead

Over the past six months, Incyte’s shares (currently trading at $60.02) have posted a disappointing 11.8% loss while the S&P 500 was down 1.7%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

3 Reasons to Sell DNB and 1 Stock to Buy Instead

Dun & Bradstreet’s stock price has taken a beating over the past six months, shedding 22.3% of its value and falling to $8.94 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

3 Reasons to Avoid OLO and 1 Stock to Buy Instead

While the broader market has struggled with the S&P 500 down 1.7% since October 2024, Olo has surged ahead as its stock price has climbed by 30% to $6.29 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

3 Reasons to Sell IP and 1 Stock to Buy Instead

While the broader market has struggled with the S&P 500 down 1.7% since October 2024, International Paper has surged ahead as its stock price has climbed by 8.2% to $53.24 per share. This run-up might have investors contemplating their next move.